{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:17:41Z","timestamp":1776125861589,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.tvjl.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T12:53:14Z","timestamp":1539694394000},"page":"39-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Dosage escalation of intravenous cyclophosphamide in cats with cancer"],"prefix":"10.1016","volume":"242","author":[{"given":"A.S.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2041-334X","authenticated-orcid":false,"given":"A.E.","family":"Frimberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8063-9223","authenticated-orcid":false,"given":"C.M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2018.10.003_bib0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2460\/ajvr.70.6.770","article-title":"Phase I evaluation of carboplatin by use of a dosing strategy based on a targeted area under the platinum concentration-versus-time curve and individual glomerular filtration rate in cats with tumors","volume":"70","author":"Bailey","year":"2009","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0010","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1634\/theoncologist.10-2-138","article-title":"Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin\u2019s lymphoma","volume":"10","author":"Blayney","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.tvjl.2018.10.003_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1043661802002098","article-title":"Emesis: antiemetic effect of cyclophosphamide at central receptors of multitransmitter system in the cat","volume":"46","author":"Bosnjak","year":"2002","journal-title":"Pharmacol. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.tvjl.2018.10.003_bib0020","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2460\/javma.1971.158.06.1130","article-title":"Treatment of leukemia in the cat","volume":"158","author":"Carpenter","year":"1971","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0025","first-page":"1130","article-title":"In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse","volume":"25","author":"Chauret","year":"1997","journal-title":"Drug Metab. Dispos."},{"issue":"Suppl. 1","key":"10.1016\/j.tvjl.2018.10.003_bib0030","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/vco.12158","article-title":"Treatment of feline intermediate- to high-grade lymphoma with a modified university of Wisconsin\u2013Madison protocol: 119 cases (2004\u20132012)","volume":"14","author":"Collette","year":"2016","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0035","first-page":"166","article-title":"Treatment of lymphoma and leukemia with cyclophosphamide, vincristine, and prednisone: II. treatment of cats","volume":"19","author":"Cotter","year":"1983","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0040","first-page":"259","article-title":"Cyclophosphamide-induced cystitis in the dog and cat","volume":"171","author":"Crow","year":"1977","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0045","series-title":"Textbook of Veterinary Internal Medicine","first-page":"235","article-title":"Leucopenia, leukocytosis","author":"DeClue","year":"2017"},{"key":"10.1016\/j.tvjl.2018.10.003_bib0050","first-page":"1625","article-title":"Vomiting induced by cyclophosphamide and phosphoramide mustard in cats","volume":"66","author":"Fetting","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1046\/j.1523-1755.2002.00279.x","article-title":"Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency","volume":"61","author":"Haubitz","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0060","first-page":"4","article-title":"Treatment of cyclophosphamide-induced cystitis","volume":"187","author":"Henness","year":"1985","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0065","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1292\/jvms.11-0098","article-title":"Expression of two novel cytochrome P450 3A131 and 3A132 in liver and small intestine of domestic cats","volume":"73","author":"Honda","year":"2011","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0070","first-page":"174","article-title":"Chemotherapy of lymphoma in 75 cats","volume":"190","author":"Jeglum","year":"1987","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1939-1676.2007.0017.x","article-title":"Phase I clinical evaluation of carboplatin in tumor-bearing cats: a Veterinary Cooperative Oncology Group study","volume":"22","author":"Kisseberth","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0080","first-page":"227","article-title":"A summary of responses to cancer therapy in cats","volume":"61","author":"Ladiges","year":"1980","journal-title":"Mod. Vet. Pract."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0085","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jnci\/djp079","article-title":"Dose escalation methods in phase I cancer clinical trials","volume":"101","author":"Le Tourneau","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1939-1676.1988.tb02794.x","article-title":"Efficacy and toxicity of doxorubicin and cyclophosphamide used in the treatment of selected malignant tumors in 23 cats","volume":"2","author":"Mauldin","year":"1988","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0095","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/vr.152.16.506","article-title":"Thiazole orange-positive platelets in cats with thrombocytopenia induced by cyclophosphamide","volume":"152","author":"Okamura","year":"2003","journal-title":"Vet. Rec."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2460\/ajvr.67.3.510","article-title":"Phase I trial and pharmacokinetic analysis of ifosfamide in cats with sarcomas","volume":"67","author":"Rassnick","year":"2006","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0105","first-page":"1319","article-title":"Effects of cyclophosphamide in dogs and cats","volume":"188","author":"Stanton","year":"1986","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0110","doi-asserted-by":"crossref","first-page":"862","DOI":"10.2460\/ajvr.78.7.862","article-title":"Pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in cats after oral, intravenous, and intraperitoneal administration of cyclophosphamide","volume":"78","author":"Stroda","year":"2017","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1939-1676.2002.tb02352.x","article-title":"Chemotherapy with cyclophosphamide, vincristine, and prednisolone (COP) in cats with malignant lymphoma: new results with an old protocol","volume":"16","author":"Teske","year":"2002","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0120","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/vco.283","article-title":"Veterinary cooperative oncology group \u2014 common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1","volume":"14","author":"VCOG","year":"2016","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.tvjl.2018.10.003_bib0125","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/CAD.0000000000000162","article-title":"Bioavailability of cyclophosphamide and vincristine after intraperitoneal administration in cats","volume":"25","author":"Voorhorst","year":"2014","journal-title":"Anticancer Drugs"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318301977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023318301977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:17:36Z","timestamp":1775247456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023318301977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":25,"alternative-id":["S1090023318301977"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2018.10.003","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosage escalation of intravenous cyclophosphamide in cats with cancer","name":"articletitle","label":"Article Title"},{"value":"The Veterinary Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvjl.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}